Clinical Characteristics of Patients and Initial Therapy According to Diagnosis
. | Indolent B-cell Lymphoma . | CD30+ Large T-cell Lymphoma . | Pleomorphic Small T-cell Lymphoma . | Large B-cell Lymphoma of the Leg . | CD30− Large T-cell Lymphoma . | Total3-150 (%) . |
---|---|---|---|---|---|---|
Median age | 68 | 54 | 59 | 78 | 53.5 | |
Sex | ||||||
Male | 38 | 20 | 22 | 7 | 13 | 100 (64) |
Female | 27 | 10 | 5 | 12 | 3 | 57 (36) |
Distribution | ||||||
Local | 34 | 14 | 7 | 9 | 7 | 71 (45) |
Regional | 7 | 6 | 5 | 7 | 0 | 26 (17) |
Generalized | 24 | 10 | 15 | 3 | 9 | 60 (38) |
LDH | ||||||
Normal | 57 | 26 | 25 | 16 | 9 | 132 (89) |
High | 6 | 3 | 1 | 1 | 6 | 17 (11) |
B symptoms | ||||||
Absence | 64 | 28 | 26 | 18 | 11 | 147 (94) |
Presence | 1 | 2 | 1 | 1 | 5 | 10 (6) |
Initial therapy | ||||||
Polychemotherapy | 19 | 9 | 5 | 14 | 9 | 56 (36) |
Monochemotherapy | 8 | 0 | 8 | 1 | 0 | 17 (11) |
Radiotherapy | 26 | 8 | 4 | 4 | 5 | 47 (30) |
Excision | 4 | 1 | 1 | 0 | 1 | 7 (4) |
Interferon | 0 | 0 | 4 | 0 | 0 | 4 (3) |
Other | 2 | 2 | 4 | 0 | 0 | 8 (5) |
Abstention | 5 | 103-151 | 1 | 0 | 1 | 18 (11) |
. | Indolent B-cell Lymphoma . | CD30+ Large T-cell Lymphoma . | Pleomorphic Small T-cell Lymphoma . | Large B-cell Lymphoma of the Leg . | CD30− Large T-cell Lymphoma . | Total3-150 (%) . |
---|---|---|---|---|---|---|
Median age | 68 | 54 | 59 | 78 | 53.5 | |
Sex | ||||||
Male | 38 | 20 | 22 | 7 | 13 | 100 (64) |
Female | 27 | 10 | 5 | 12 | 3 | 57 (36) |
Distribution | ||||||
Local | 34 | 14 | 7 | 9 | 7 | 71 (45) |
Regional | 7 | 6 | 5 | 7 | 0 | 26 (17) |
Generalized | 24 | 10 | 15 | 3 | 9 | 60 (38) |
LDH | ||||||
Normal | 57 | 26 | 25 | 16 | 9 | 132 (89) |
High | 6 | 3 | 1 | 1 | 6 | 17 (11) |
B symptoms | ||||||
Absence | 64 | 28 | 26 | 18 | 11 | 147 (94) |
Presence | 1 | 2 | 1 | 1 | 5 | 10 (6) |
Initial therapy | ||||||
Polychemotherapy | 19 | 9 | 5 | 14 | 9 | 56 (36) |
Monochemotherapy | 8 | 0 | 8 | 1 | 0 | 17 (11) |
Radiotherapy | 26 | 8 | 4 | 4 | 5 | 47 (30) |
Excision | 4 | 1 | 1 | 0 | 1 | 7 (4) |
Interferon | 0 | 0 | 4 | 0 | 0 | 4 (3) |
Other | 2 | 2 | 4 | 0 | 0 | 8 (5) |
Abstention | 5 | 103-151 | 1 | 0 | 1 | 18 (11) |